Philip R. Lee Institute for Health Policy Studies

Current COVID-19 Related Research and Initiatives
IHPS faculty are responding to policy challenges raised by the COVID-19
 pandemic with rapid-cycle research and technical assistance.
Harold S. Luft Mentoring Award
We are delighted to announce that Mary Whooley, MD has been selected as this year's recipient of the Harold S. Luft Award for Mentoring in Health Services and Health Policy Research, awarded by the Philip R. Lee Institute for Health Policy Studies.
New IHPS Fellow
Sarah B. Garrett, PhD, is a new Fellow at the Philip R. Lee Institute for Health Policy Studies. As a Fellow, Sarah will focus on the implementation and effects of interventions intended to reduce maternal mortality in the U.S., particularly among communities disproportionately affected by it.


Featured Story -

Drug Overdose Deaths Spike During the Pandemic

Prescription Pain Pills
(iStock Photo)

Emerging evidence shows that drug overdose deaths are surging from increased substance abuse driven by feelings of isolation, anxiety and depression during the coronavirus pandemic. Fatal drug overdoses were already ticking upward in 2019, according to preliminary data from the Centers for Disease Control and Prevention -- a trend the pandemic is accelerating. And more challenging, many treatment programs have been scaled back as the federal government puts some funding for non-COVID-related work on hold indefinitely.

Guests: Dr. Nora Volkow, director, National Institute on Drug Abuse

Joanne Spetz, director, UCSF Health Workforce Research Center; associate director of research at the Philip R. Lee Institure for Health Policy Studies and the UCSF Healthforce Center

Listen here:

Using Care Navigation to Address Caregiver Burden in Dementia: A Qualitative Case Study Analysis

Senioir Women

In a recent article in Alzheimer’s & Dementia: Translational Research & Clinical Interventions, Alissa Bernstein, PhD, Krista Harrison, PhD, and Dan Dohan, PhD, along with their colleagues, provide an in-depth understanding of how unlicensed but expertly trained dementia care navigators, supported by a small clinical team, can use phone and web-based care navigation to address caregiver burden among caregivers of people with dementia.

More than 15 million family members or friends care for individuals with Alzheimer's disease and related dementias in the United States, which involves providing emotional, physical, and practical support. Many caregivers experience burden and resulting health effects due to the intensive nature of caregiving. Caregiver burden, which has been studied extensively in the literature, may also be a factor leading to premature institutionalization of individuals with dementia.

Read more:

Testing Cascades—A Call to Move From Descriptive Research to Deimplementation Science

JAMA Journel Article Icon

Timothy S. Anderson and Grace A. Lin
JAMA Intern Med. Published online June 8, 2020.

Over the past decade, attention to overuse of testing has steadily grown, reflected by the addition of low-value care, Choosing Wisely, less is more, and cost-conscious care to the medical vernacular. Despite widespread recognition of this issue, there has been little evidence of large-scale changes in testing practices in the US. There may be many barriers to reducing overuse, including a fee-for-service payment model that disincentivizes physicians and health systems from reducing use of revenue-generating tests, a belief that more testing is beneficial, and framing of the issue as largely a problem of health care costs.

Read more: